SurModics (SRDX) Tops Q1 EPS by 21c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. USO
3. SPY
4. OPCH
5. BBIO
6. NVDA
7. GOOGL
8. CHRW
9. AMD
10. STZ

Go back to SurModics (SRDX) Tops Q1 EPS by 21c

SurModics Reports First Quarter Fiscal 2016 Results

January 28, 2016 7:35 AM EST

GAAP Revenue of $16.5 Million, up 16% GAAP EPS of $0.19, Non-GAAP EPS of $0.38 Fiscal 2016 Guidance Reaffirmed

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- SurModics, Inc. (NASDAQ: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2016 first quarter, ended December 31, 2015.

The SurModics team had an exceptional first quarter of fiscal 2016, said Gary Maharaj, president and chief executive officer. We delivered outstanding results from our core Medical Device and In Vitro Diagnostic... More